Technological Advancements in Drug Delivery
Technology is shaping the future of the Eylea Market. Sustained-release implants and refillable eye reservoirs are under development, aiming to reduce injection frequency and improve patient compliance. High-dose versions of Eylea already extend treatment intervals, easing the burden on patients and clinics. Integrating digital tools like treatment reminder apps and tele-ophthalmology services can further enhance patient experience and adherence.